Dr. Brown is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2995 Woodside Rd
Suite 400
Redwood City, CA 94062Phone+1 650-845-7755
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1978 - 1980- Brigham and Women's HospitalResidency, Internal Medicine, 1976 - 1978
University of Rochester School of Medicine and DentistryClass of 1976
Certifications & Licensure
CA State Medical License 1990 - 2025
MA State Medical License 1978 - 2023- American Board of Internal Medicine Internal Medicine
Clinical Trials
- Phase 2 Study of Telintra® in Deletion 5q Myelodysplastic Syndrome Start of enrollment: 2011 Oct 01
- Study of (Telintra®) in Non-Del(5q) Myelodysplastic Syndrome Start of enrollment: 2011 Oct 01
Publications & Presentations
PubMed
- 14 citationsPrediction of response to therapy with ezatiostat in lower risk myelodysplastic syndromeNaomi Galili, Pablo Tamayo, Olga B Botvinnik, Jill P. Mesirov, Margarita R Brooks
Journal of Hematology & Oncology. 2012-05-06 - 34 citationsA phase 2 randomized multicenter study of 2 extended dosing schedules of oral ezatiostat in low to intermediate-1 risk myelodysplastic syndromeAzra Raza, Naomi Galili, Scott E. Smith, John E. Godwin, Ralph V. Boccia
Cancer. 2012-04-15 - 15 citationsOral ezatiostat HCl (Telintra®, TLK199) and Idiopathic Chronic Neutropenia (ICN): a case report of complete response of a patient with G-CSF resistant ICN following tr...Roger M. Lyons, Sharon T. Wilks, Shelby Young, Gail L. Brown
Journal of Hematology & Oncology. 2011-11-02
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
